A novel neutralizing monoclonal antibody targeting the N-terminal domain of the MERS-CoV spike protein

Isolation of a Novel Coronavirus from a Man with Pneumonia in Saudi Arabia

Zaki, A. M., van Boheemen, S., Bestebroer, T. M., Osterhaus, A. D. M. E., & Fouchier, R. A. M. (2012) · New England Journal of Medicine · doi:10.1056/nejmoa1211721 · Cited by 5,677 · see citing works

Virus taxonomy: classification and nomenclature of viruses

King, A. M. Q., Adams, M. J., Carstens, E. B., & Lefkowitz, E. J. (2012) · Cited by 2,088 · see citing works

Dipeptidyl peptidase 4 is a functional receptor for the emerging human coronavirus-EMC

Raj, V. S., Mou, H., Smits, S. L., Dekkers, D. H. W., Müller, M. A., Dijkman, R., Muth, D., Demmers, J. A. A., Zaki, A., Fouchier, R. A. M., et al. (2013) · Nature · doi:10.1038/nature12005 · Cited by 2,061 · see citing works

Hospital outbreak of Middle East respiratory syndrome coronavirus

Assiri, A., McGeer, A., Perl, T. M., Price, C. S., Al Rabeeah, A. A., Cummings, D. A. T., Alabdullatif, Z. N., Assad, M., Almulhim, A., Makhdoom, H., et al. (2013) · New England Journal of Medicine · doi:10.1056/nejmoa1306742 · Cited by 1,196 · see citing works

Genomic Characterization of a Newly Discovered Coronavirus Associated with Acute Respiratory Distress Syndrome in Humans

van Boheemen, S., de Graaf, M., Lauber, C., Bestebroer, T. M., Raj, V. S., Zaki, A. M., Osterhaus, A. D. M. E., Haagmans, B. L., Gorbalenya, A. E., Snijder, E. J., et al. (2012) · mBio · doi:10.1128/mbio.00473-12 · Cited by 911 · see citing works

Middle East Respiratory Syndrome Coronavirus: Another Zoonotic Betacoronavirus Causing SARS-Like Disease

Chan, J. F., Lau, S. K. P., To, K. K., Cheng, V. C., Woo, P. C. Y., & Yuen, K. (2015) · Clinical Microbiology Reviews · doi:10.1128/cmr.00102-14 · Cited by 876 · see citing works

Pre-fusion structure of a human coronavirus spike protein

Kirchdoerfer, R. N., Cottrell, C. A., Wang, N., Pallesen, J., Yassine, H. M., Turner, H. L., Corbett, K. S., Graham, B. S., McLellan, J. S., & Ward, A. B. (2016) · Nature · doi:10.1038/nature17200 · Cited by 765 · see citing works

Molecular basis of binding between novel human coronavirus MERS-CoV and its receptor CD26

Lu, G., Hu, Y., Wang, Q., Qi, J., Gao, F., Li, Y., Zhang, Y., Zhang, W., Yuan, Y., Bao, J., et al. (2013) · Nature · doi:10.1038/nature12328 · Cited by 732 · see citing works

Structure of MERS-CoV spike receptor-binding domain complexed with human receptor DPP4

Wang, N., Shi, X., Jiang, L., Zhang, S., Wang, D., Tong, P., Guo, D., Fu, L., Cui, Y., Liu, X., et al. (2013) · Cell Research · doi:10.1038/cr.2013.92 · Cited by 717 · see citing works

Host cell entry of Middle East respiratory syndrome coronavirus after two-step, furin-mediated activation of the spike protein

Millet, J. K., & Whittaker, G. R. (2014) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1407087111 · Cited by 673 · see citing works

Middle East respiratory syndrome coronavirus in dromedary camels: an outbreak investigation

Haagmans, B. L., Dhahiry, S. H. S. A., Reusken, C. B. E. M., Raj, V. S., Galiano, M., Myers, R. E., Godeke, G.-J., Jonges, M., Farag, E., Diab, A. H. M., et al. (2013) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(13)70690-x · Cited by 672 · see citing works

Cryo-electron microscopy structures of the SARS-CoV spike glycoprotein reveal a prerequisite conformational state for receptor binding

Gui, M., Song, W., Zhou, H., Xu, J., Chen, S., Xiang, Y., & Wang, X. (2016) · Cell Research · doi:10.1038/cr.2016.152 · Cited by 577 · see citing works

Structural Delineation of a Quaternary, Cleavage-Dependent Epitope at the gp41-gp120 Interface on Intact HIV-1 Env Trimers

Blattner, C., Lee, J. H., Sliepen, K., Derking, R., Falkowska, E., de la Peña, A. T., Cupo, A., Julien, J., van Gils, M. J., Lee, P. S., et al. (2014) · Immunity · doi:10.1016/j.immuni.2014.04.008 · Cited by 332 · see citing works

Evaluation of candidate vaccine approaches for MERS-CoV

Wang, L., Shi, W., Joyce, M. G., Modjarrad, K., Zhang, Y., Leung, K., Lees, C. R., Zhou, T., Yassine, H. M., Kanekiyo, M., et al. (2015) · Nature Communications · doi:10.1038/ncomms8712 · Cited by 300 · see citing works

Receptor usage and cell entry of bat coronavirus HKU4 provide insight into bat-to-human transmission of MERS coronavirus

Yang, Y., Du, L., Liu, C., Wang, L., Ma, C., Tang, J., Baric, R. S., Jiang, S., & Li, F. (2014) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1405889111 · Cited by 279 · see citing works

The Receptor Binding Domain of the New Middle East Respiratory Syndrome Coronavirus Maps to a 231-Residue Region in the Spike Protein That Efficiently Elicits Neutralizing Antibodies

Mou, H., Raj, V. S., van Kuppeveld, F. J. M., Rottier, P. J. M., Haagmans, B. L., & Bosch, B. (2013) · Journal of Virology · doi:10.1128/jvi.01277-13 · Cited by 239 · see citing works

Receptor-Binding Domain of Severe Acute Respiratory Syndrome Coronavirus Spike Protein Contains Multiple Conformation-Dependent Epitopes that Induce Highly Potent Neutralizing Antibodies

He, Y., Lü, H., Siddiqui, P., Zhou, Y., & Jiang, S. (2005) · The Journal of Immunology · doi:10.4049/jimmunol.174.8.4908 · Cited by 237 · see citing works

Exceptionally Potent Neutralization of Middle East Respiratory Syndrome Coronavirus by Human Monoclonal Antibodies

Ying, T., Du, L., Ju, T. W., Prabakaran, P., Lau, C. C. Y., Lu, L., Liu, Q., Wang, L., Feng, Y., Wang, Y., et al. (2014) · Journal of Virology · doi:10.1128/jvi.00912-14 · Cited by 233 · see citing works

Identification of human neutralizing antibodies against MERS-CoV and their role in virus adaptive evolution

Tang, X.-C., Agnihothram, S. S., Jiao, Y., Stanhope, J., Graham, R. L., Peterson, E. C., Avnir, Y., Tallarico, A. S. C., Sheehan, J., Zhu, Q., et al. (2014) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1402074111 · Cited by 232 · see citing works

2015 MERS outbreak in Korea: hospital-to-hospital transmission

Ki, M. (2015) · Epidemiology and Health · doi:10.4178/epih/e2015033 · Cited by 229 · see citing works

Pre- and postexposure efficacy of fully human antibodies against Spike protein in a novel humanized mouse model of MERS-CoV infection

Pascal, K. E., Coleman, C. M., Mujica, A. O., Kamat, V., Badithe, A., Fairhurst, J. L., Hunt, C., Strein, J., Berrebi, A. A., Sisk, J. M., et al. (2015) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1510830112 · Cited by 217 · see citing works

Prophylactic and postexposure efficacy of a potent human monoclonal antibody against MERS coronavirus

Corti, D., Zhao, J., Pedotti, M., Simonelli, L., Agnihothram, S., Fett, C., Fernandez-Rodriguez, B., Foglierini, M., Agatic, G., Vanzetta, F., et al. (2015) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1510199112 · Cited by 216 · see citing works

Potent Neutralization of MERS-CoV by Human Neutralizing Monoclonal Antibodies to the Viral Spike Glycoprotein

Jiang, L., Wang, N., Zuo, T., Shi, X., Poon, V. K., Wu, Y., Gao, F., Li, D., Wang, R., Guo, J., et al. (2014) · Science Translational Medicine · doi:10.1126/scitranslmed.3008140 · Cited by 215 · see citing works

Middle East Respiratory Syndrome Coronavirus Infections in Health Care Workers

Memish, Z. A., Zumla, A. I., & Assiri, A. M. (2013) · New England Journal of Medicine · doi:10.1056/nejmc1308698 · Cited by 206 · see citing works

Crystal structure of mouse coronavirus receptor-binding domain complexed with its murine receptor

Peng, G., Sun, D., Rajashankar, K. R., Qian, Z., Holmes, K. V., & Li, F. (2011) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1104306108 · Cited by 199 · see citing works

Environmental Contamination and Viral Shedding in MERS Patients During MERS-CoV Outbreak in South Korea

Bin, S. Y., Heo, J. Y., Song, M., Lee, J., Kim, E.-H., Park, S., Kwon, H.-I., Kim, S., Kim, Y., Si, Y., et al. (2015) · Clinical Infectious Diseases · doi:10.1093/cid/civ1020 · Cited by 188 · see citing works

Identification of a Receptor-Binding Domain in the S Protein of the Novel Human Coronavirus Middle East Respiratory Syndrome Coronavirus as an Essential Target for Vaccine Development

Du, L., Zhao, G., Kou, Z., Ma, C., Sun, S., Poon, V. K., Lu, L., Wang, L., Debnath, A. K., Zheng, B.-J., et al. (2013) · Journal of Virology · doi:10.1128/jvi.01048-13 · Cited by 175 · see citing works

Most neutralizing human monoclonal antibodies target novel epitopes requiring both Lassa virus glycoprotein subunits

Robinson, J. E., Hastie, K. M., Cross, R. W., Yenni, R. E., Elliott, D. H., Rouelle, J. A., Kannadka, C. B., Smira, A. R., Garry, C. E., Bradley, B. T., et al. (2016) · Nature Communications · doi:10.1038/ncomms11544 · Cited by 168 · see citing works

Is the discovery of the novel human betacoronavirus 2c EMC/2012 (HCoV-EMC) the beginning of another SARS-like pandemic?

Chan, J. F., Li, K. S. M., To, K. K., Cheng, V. C., Chen, H., & Yuen, K. (2012) · Journal of Infection · doi:10.1016/j.jinf.2012.10.002 · Cited by 162 · see citing works

Middle East Respiratory Syndrome Coronavirus Quasispecies That Include Homologues of Human Isolates Revealed through Whole-Genome Analysis and Virus Cultured from Dromedary Camels in Saudi Arabia

Briese, T., Mishra, N., Jain, K., Zalmout, I. S., Jabado, O., Karesh, W. B., Daszak, P., Mohammed, O. B., Alagaili, A. N., & Lipkin, W. I. (2014) · mBio · doi:10.1128/mbio.01146-14 · Cited by 159 · see citing works

A Truncated Receptor-Binding Domain of MERS-CoV Spike Protein Potently Inhibits MERS-CoV Infection and Induces Strong Neutralizing Antibody Responses: Implication for Developing Therapeutics and Vaccines

Du, L., Kou, Z., Ma, C., Tao, X., Wang, L., Zhao, G., Chen, Y.-Q., Yu, F., Tseng, C.-T. K., Zhou, Y., et al. (2013) · PLoS ONE · doi:10.1371/journal.pone.0081587 · Cited by 157 · see citing works

Transmissible gastroenteritis coronavirus, but not the related porcine respiratory coronavirus, has a sialic acid (N-glycolylneuraminic acid) binding activity

Schultze, B., Krempl, C. D., Ballesteros, M. L., Shaw, L., Schauer, R., Enjuanes, L., & Herrler, G. (1996) · Journal of Virology · doi:10.1128/jvi.70.8.5634-5637.1996 · Cited by 154 · see citing works

Full-Genome Deep Sequencing and Phylogenetic Analysis of Novel Human Betacoronavirus

Cotten, M. L., Lam, T. T., Watson, S. J., Palser, A. L., Petrova, V. N., Grant, P. R., Pybus, O. G., Rambaut, A., Guan, Y., Pillay, D., et al. (2013) · Emerging infectious diseases · doi:10.3201/eid1905.130057 · Cited by 150 · see citing works

A humanized neutralizing antibody against MERS-CoV targeting the receptor-binding domain of the spike protein

Li, Y., Wan, Y., Liu, P., Zhao, J., Lu, G., Qi, J., Wang, Q., Lu, X., Wu, Y., Liu, W., et al. (2015) · Cell Research · doi:10.1038/cr.2015.113 · Cited by 150 · see citing works

The emerging novel Middle East respiratory syndrome coronavirus: The “knowns” and “unknowns”

Chan, J. F., Lau, S. K. P., & Woo, P. C. Y. (2013) · Journal of the Formosan Medical Association · doi:10.1016/j.jfma.2013.05.010 · Cited by 144 · see citing works

Intranasal vaccination with recombinant receptor-binding domain of MERS-CoV spike protein induces much stronger local mucosal immune responses than subcutaneous immunization: Implication for designing novel mucosal MERS vaccines

Ma, C., Li, Y., Wang, L., Zhao, G., Tao, X., Tseng, C.-T. K., Zhou, Y., Du, L., & Jiang, S. (2014) · Vaccine · doi:10.1016/j.vaccine.2014.02.004 · Cited by 138 · see citing works

A Conformation-Dependent Neutralizing Monoclonal Antibody Specifically Targeting Receptor-Binding Domain in Middle East Respiratory Syndrome Coronavirus Spike Protein

Du, L., Zhao, G., Yang, Y., Qiu, H., Wang, L., Kou, Z., Tao, X., Yu, H., Sun, S., Tseng, C.-T. K., et al. (2014) · Journal of Virology · doi:10.1128/jvi.00433-14 · Cited by 138 · see citing works

Crystal Structure of the Receptor-Binding Domain from Newly Emerged Middle East Respiratory Syndrome Coronavirus

Chen, Y.-Q., Rajashankar, K. R., Yang, Y., Agnihothram, S., Liu, C., Lin, Y.-L., Baric, R. S., & Li, F. (2013) · Journal of Virology · doi:10.1128/jvi.01756-13 · Cited by 135 · see citing works

Searching for an ideal vaccine candidate among different MERS coronavirus receptor-binding fragments—The importance of immunofocusing in subunit vaccine design

Ma, C., Wang, L., Tao, X., Zhang, N., Yang, Y., Tseng, C.-T. K., Li, F., Zhou, Y., Jiang, S., & Du, L. (2014) · Vaccine · doi:10.1016/j.vaccine.2014.08.086 · Cited by 131 · see citing works

Identification and Comparison of Receptor Binding Characteristics of the Spike Protein of Two Porcine Epidemic Diarrhea Virus Strains

Deng, F., Ye, G., Liu, Q., Navid, M. T., Zhong, X., Li, Y., Wan, C., Xiao, S., He, Q., Fu, Z. F., et al. (2016) · Viruses · doi:10.3390/v8030055 · Cited by 129 · see citing works

Recombinant Receptor Binding Domain Protein Induces Partial Protective Immunity in Rhesus Macaques Against Middle East Respiratory Syndrome Coronavirus Challenge

Lan, J., Yao, Y., Deng, Y. L., Chen, H., Lu, G., Wang, W., Bao, L., Deng, W., Wei, Q., Gao, G. F., et al. (2015) · EBioMedicine · doi:10.1016/j.ebiom.2015.08.031 · Cited by 111 · see citing works

Evidence of person-to-person transmission within a family cluster of novel coronavirus infections, United Kingdom, February 2013.

Tahir, M., Gajraj, R., Bardhan, M., Mohammed, H., Dyke, L., Charlemagne, P., Alves, R., Kirrage, D., Killalea, D., James, K., et al. (2013) · UCL Discovery (University College London) · Cited by 110 · see citing works

Probable transmission chains of Middle East respiratory syndrome coronavirus and the multiple generations of secondary infection in South Korea

Lee, S. S., & Wong, N. S. (2015) · International Journal of Infectious Diseases · doi:10.1016/j.ijid.2015.07.014 · Cited by 80 · see citing works

Optimization of antigen dose for a receptor-binding domain-based subunit vaccine against MERS coronavirus

Tang, J., Zhang, N., Tao, X., Zhao, G., Guo, Y., Tseng, C.-T. K., Jiang, S., Du, L., & Zhou, Y. (2015) · Human Vaccines & Immunotherapeutics · doi:10.1080/21645515.2015.1021527 · Cited by 77 · see citing works

Prevalence of Middle East respiratory syndrome coronavirus (MERS-CoV) in dromedary camels in Abu Dhabi Emirate, United Arab Emirates

Yusof, M. F., Eltahir, Y. M., Serhan, W. S., Hashem, F. M., Elsayed, E. A., Marzoug, B. A., Abdelazim, A. S., Bensalah, O. K., & Muhairi, S. S. M. A. (2015) · Virus Genes · doi:10.1007/s11262-015-1174-0 · Cited by 69 · see citing works

Receptor-binding domain-based subunit vaccines against MERS-CoV

Zhang, N., Tang, J., Lu, L., Jiang, S., & Du, L. (2014) · Virus Research · doi:10.1016/j.virusres.2014.11.013 · Cited by 61 · see citing works

MERS-CoV vaccine candidates in development: The current landscape

Modjarrad, K. (2016) · Vaccine · doi:10.1016/j.vaccine.2016.03.104 · Cited by 52 · see citing works

Middle East respiratory syndrome: current status and future prospects for vaccine development

Du, L., & Jiang, S. (2015) · Expert Opinion on Biological Therapy · doi:10.1517/14712598.2015.1092518 · Cited by 43 · see citing works

A predicted receptor-binding and critical neutralizing domain in S protein of the novel human coronavirus HCoV-EMC

Jiang, S., Lu, L., Du, L., & Debnath, A. K. (2012) · Journal of Infection · doi:10.1016/j.jinf.2012.12.003 · Cited by 41 · see citing works

Putative conformations of the receptor-binding domain in S protein of hCoV-EMC in complex with its receptor dipeptidyl peptidase-4

Jiang, S., Lu, L., Du, L., & Debnath, A. K. (2013) · Journal of Infection · doi:10.1016/j.jinf.2013.04.007 · Cited by 12 · see citing works

Tracking Changes in SARS-CoV-2 Spike: Evidence that D614G Increases Infectivity of the COVID-19 Virus

Korber, B., Fischer, W. M., Gnanakaran, S., Yoon, H., Theiler, J., Abfalterer, W., Hengartner, N., Giorgi, E. E., Bhattacharya, T., Foley, B., et al. (2020) · Cell · doi:10.1016/j.cell.2020.06.043 · Cited by 4,281 · see citing works

Evaluation of the mRNA-1273 Vaccine against SARS-CoV-2 in Nonhuman Primates

Corbett, K. S., Flynn, B., Foulds, K. E., Francica, J. R., Boyoglu-Barnum, S., Werner, A. P., Flach, B., O’Connell, S., Bock, K. W., Minai, M., et al. (2020) · New England Journal of Medicine · doi:10.1056/nejmoa2024671 · Cited by 1,066 · see citing works

N-terminal domain antigenic mapping reveals a site of vulnerability for SARS-CoV-2

McCallum, M., De Marco, A., Lempp, F. A., Tortorici, M. A., Pinto, D., Walls, A. C., Beltramello, M., Chen, A., Liu, Z., Zatta, F., et al. (2021) · Cell · doi:10.1016/j.cell.2021.03.028 · Cited by 901 · see citing works

Immunological mechanisms of vaccine-induced protection against COVID-19 in humans

Sadarangani, M., Marchant, A., & Kollmann, T. R. (2021) · Nature Reviews Immunology · doi:10.1038/s41577-021-00578-z · Cited by 560 · see citing works

Potent SARS-CoV-2 neutralizing antibodies directed against spike N-terminal domain target a single supersite

Cerutti, G., Guo, Y., Zhou, T., Gorman, J., Lee, M., Rapp, M., Reddem, E. R., Yu, J., Bahna, F., Bimela, J., et al. (2021) · Cell Host & Microbe · doi:10.1016/j.chom.2021.03.005 · Cited by 519 · see citing works

A Universal Design of Betacoronavirus Vaccines against COVID-19, MERS, and SARS

Dai, L., Zheng, T., Xu, K., Han, Y., Xu, L., Huang, E., An, Y., Cheng, Y., Li, S., Liu, M., et al. (2020) · Cell · doi:10.1016/j.cell.2020.06.035 · Cited by 476 · see citing works

An emerging coronavirus causing pneumonia outbreak in Wuhan, China: calling for developing therapeutic and prophylactic strategies

Jiang, S., Du, L., & Shi, Z. (2020) · Emerging Microbes & Infections · doi:10.1080/22221751.2020.1723441 · Cited by 330 · see citing works

Progress and Prospects on Vaccine Development against SARS-CoV-2

Zhang, J., Zeng, H., Gu, J., Li, H., Zheng, L., & Zou, Q. (2020) · Vaccines · doi:10.3390/vaccines8020153 · Cited by 280 · see citing works

Plant and animal small RNA communications between cells and organisms

Chen, X., & Rechavi, O. (2021) · Nature Reviews Molecular Cell Biology · doi:10.1038/s41580-021-00425-y · Cited by 168 · see citing works

Importance of Neutralizing Monoclonal Antibodies Targeting Multiple Antigenic Sites on the Middle East Respiratory Syndrome Coronavirus Spike Glycoprotein To Avoid Neutralization Escape

Wang, L., Shi, W., Chappell, J. D., Joyce, M. G., Zhang, Y., Kanekiyo, M., Becker, M. M., van Doremalen, N., Fischer, R., Wang, N., et al. (2018) · Journal of Virology · doi:10.1128/jvi.02002-17 · Cited by 169 · see citing works

Microstructure, pathophysiology, and potential therapeutics of COVID‐19: A comprehensive review

Singh, S. P., Pritam, M., Pandey, B., & Yadav, T. P. (2021) · Journal of Medical Virology · doi:10.1002/jmv.26254 · Cited by 166 · see citing works

Structural definition of a neutralization epitope on the N-terminal domain of MERS-CoV spike glycoprotein

Zhou, H., Chen, Y., Zhang, S., Niu, P., Qin, K., Jia, W., Huang, B., Zhang, S., Lan, J., Zhang, L., et al. (2019) · Nature Communications · doi:10.1038/s41467-019-10897-4 · Cited by 142 · see citing works

N-terminal domain antigenic mapping reveals a site of vulnerability for SARS-CoV-2

McCallum, M., Marco, A. D., Lempp, F., Tortorici, M. A., Pinto, D., Walls, A. C., Beltramello, M., Chen, A., Liu, Z., Zatta, F., et al. (2021) · doi:10.1101/2021.01.14.426475 · Cited by 901 · see citing works

Molecular diversity of coronavirus host cell entry receptors

Millet, J. K., Jaimes, J. A., & Whittaker, G. R. (2020) · FEMS Microbiology Reviews · doi:10.1093/femsre/fuaa057 · Cited by 129 · see citing works

Vaccination in patients with kidney failure: lessons from COVID-19

Babel, N., Hugo, C., & Westhoff, T. H. (2022) · Nature Reviews Nephrology · doi:10.1038/s41581-022-00617-5 · Cited by 116 · see citing works

Genetic comparison among various coronavirus strains for the identification of potential vaccine targets of SARS-CoV2

Kaur, N., Singh, R., Dar, Z., Bijarnia, R. K., Dhingra, N., & Kaur, T. (2020) · Infection Genetics and Evolution · doi:10.1016/j.meegid.2020.104490 · Cited by 110 · see citing works

Distinct Roles for Sialoside and Protein Receptors in Coronavirus Infection

Qing, E., Hantak, M. P., Perlman, S. M., & Gallagher, T. (2020) · mBio · doi:10.1128/mbio.02764-19 · Cited by 100 · see citing works

Structural Definition of a Neutralization-sensitive Epitope on the MERS-CoV S1-NTD

Wang, N., Rosen, O., Wang, L., Turner, H. L., Stevens, L. J., Corbett, K. S., Bowman, C. A., Pallesen, J., Shi, W., Zhang, Y., et al. (2019) · Cell Reports · doi:10.1016/j.celrep.2019.08.052 · Cited by 86 · see citing works

Antibodies and vaccines against Middle East respiratory syndrome coronavirus

Xu, J., Jia, W., Wang, P., Zhang, S., Shi, X., Wang, X., & Zhang, L. (2019) · Emerging Microbes & Infections · doi:10.1080/22221751.2019.1624482 · Cited by 84 · see citing works

Nanomedicine as A Promising Approach For Diagnosis, Treatment and Prophylaxis Against COVID-19

Ellah, N. H. A., Gad, S. F., Muhammad, K., Batiha, G. E., & Hetta, ‏. F. (2020) · Nanomedicine · doi:10.2217/nnm-2020-0247 · Cited by 75 · see citing works

Severe acute respiratory syndrome‐coronavirus‐2 spike (S) protein based vaccine candidates: State of the art and future prospects

Arashkia, A., Jalilvand, S., Mohajel, N., Afchangi, A., Azadmanesh, K., Salehi-Vaziri, ‪., Fazlalipour, M., Pouriayevali, M. H., Jalali, T., Nasab, S. D. M., et al. (2020) · Reviews in Medical Virology · doi:10.1002/rmv.2183 · Cited by 72 · see citing works

Structural Definition of a Unique Neutralization Epitope on the Receptor-Binding Domain of MERS-CoV Spike Glycoprotein

Zhang, S., Zhou, P.-P., Wang, P., Li, Y., Jiang, L., Jia, W., Wang, H., Fan, A., Wang, D., Shi, X., et al. (2018) · Cell Reports · doi:10.1016/j.celrep.2018.06.041 · Cited by 69 · see citing works

Characterizing Transcriptional Regulatory Sequences in Coronaviruses and Their Role in Recombination

Yang, Y., Yan, W., Hall, A. B., & Jiang, X. (2020) · Molecular Biology and Evolution · doi:10.1093/molbev/msaa281 · Cited by 64 · see citing works

Superior immune responses induced by intranasal immunization with recombinant adenovirus-based vaccine expressing full-length Spike protein of Middle East respiratory syndrome coronavirus

Kim, M. H., Kim, H. J., & Chang, J. (2019) · PLoS ONE · doi:10.1371/journal.pone.0220196 · Cited by 63 · see citing works

Identification of the immunodominant neutralizing regions in the spike glycoprotein of porcine deltacoronavirus

Chen, R., Fu, J., Hu, J., Li, C., Zhao, Y., Qu, H., Wen, X., Cao, S., Wen, Y., Wu, R. J., et al. (2019) · Virus Research · doi:10.1016/j.virusres.2019.197834 · Cited by 52 · see citing works

From SARS-CoV to SARS-CoV-2: safety and broad-spectrum are important for coronavirus vaccine development

Ma, C., Su, S., Wang, J., Wei, L., Du, L., & Jiang, S. (2020) · Microbes and Infection · doi:10.1016/j.micinf.2020.05.004 · Cited by 52 · see citing works

An updated roadmap for MERS-CoV research and product development: focus on diagnostics

Cirino, C. K., Mazzola, L. T., Chua, A., Oxenford, C. J., & Kerkhove, M. D. V. (2019) · BMJ Global Health · doi:10.1136/bmjgh-2018-001105 · Cited by 51 · see citing works

Enhanced protection in mice induced by immunization with inactivated whole viruses compare to spike protein of middle east respiratory syndrome coronavirus

Deng, Y. L., Lan, J., Bao, L., Huang, B., Ye, F., Chen, Y., Yao, Y., Wang, W., Qin, C., & Tan, W. (2018) · Emerging Microbes & Infections · doi:10.1038/s41426-018-0056-7 · Cited by 50 · see citing works

Full lockdown policies in Western Europe countries have no evident impacts on the COVID-19 epidemicPreprint

Meunier, T. (2020) · medRxiv · doi:10.1101/2020.04.24.20078717 · Cited by 50 · see citing works

Characterization of novel monoclonal antibodies against MERS-coronavirus spike protein

Goo, J., Jeong, Y., Park, Y.-S., Yang, E., Jung, D., Rho, S., Park, U., Sung, H., Park, P., Choi, J., et al. (2020) · Virus Research · doi:10.1016/j.virusres.2020.197863 · Cited by 47 · see citing works

Development of a Phage Display Panning Strategy Utilizing Crude Antigens: Isolation of MERS-CoV Nucleoprotein human antibodies

Lim, C. C., Woo, P. C. Y., & Lim, T. S. (2019) · Scientific Reports · doi:10.1038/s41598-019-42628-6 · Cited by 42 · see citing works

Significance of Conserved Regions in Coronavirus Spike Protein for Developing a Novel Vaccine against SARS-CoV-2 Infection

Olukitibi, T. A., Ao, Z., Warner, B. M., Unat, R., Kobasa, D., & Yao, X. (2023) · Vaccines · doi:10.3390/vaccines11030545 · Cited by 38 · see citing works

Species-Specific Colocalization of Middle East Respiratory Syndrome Coronavirus Attachment and Entry Receptors

Widagdo, W., Okba, N. M. A., Li, W., de Jong, A., de Swart, R. L., Begeman, L., van den Brand, J. M. A., Bosch, B., & Haagmans, B. L. (2019) · Journal of Virology · doi:10.1128/jvi.00107-19 · Cited by 38 · see citing works

Current understanding of middle east respiratory syndrome coronavirus infection in human and animal models

Wang, Y., Sun, J., Zhu, A., Zhao, J., & Zhao, J. (2018) · Journal of Thoracic Disease · doi:10.21037/jtd.2018.03.80 · Cited by 35 · see citing works

Gendered burdens and impacts of SARS-CoV-2: a review

Ayittey, F. K., Dhar, B. K., Anani, G., & Chiwero, N. B. (2020) · Health Care For Women International · doi:10.1080/07399332.2020.1809664 · Cited by 34 · see citing works

Targeted repression of Plasmodium apicortin by host microRNA impairs malaria parasite growth and invasion

Chakrabarti, M., Garg, S., Ayana, R., Pati, S., & Singh, S. (2020) · Disease Models & Mechanisms · doi:10.1242/dmm.042820 · Cited by 32 · see citing works

Emerging importance of nanotechnology-based approaches to control the COVID-19 pandemic; focus on nanomedicine iterance in diagnosis and treatment of COVID-19 patients

Hashemi, B., Firouzi‐Amandi, A., Amirazad, H., Dadashpour, M., Sheervalilou, M., Nasrabadi, D., Ahmadi, M., Sheervalilou, R., Reza, M. A. S., Ghazi, F., et al. (2021) · Journal of Drug Delivery Science and Technology · doi:10.1016/j.jddst.2021.102967 · Cited by 31 · see citing works

Middle East Respiratory Syndrome (MERS) Virus—Pathophysiological Axis and the Current Treatment Strategies

Alnuqaydan, A. M., Almutary, A. G., Sukamaran, A., Yang, B. T. W., Lee, X. T., Lim, W. X., Ng, Y. M., Ibrahim, R., Darmarajan, T., Satheeshkumar, N., et al. (2021) · AAPS PharmSciTech · doi:10.1208/s12249-021-02062-2 · Cited by 33 · see citing works

Development of Middle East Respiratory Syndrome Coronavirus vaccines – advances and challenges

Cho, H., Excler, J., Kim, J. H., & Yoon, I. (2017) · Human Vaccines & Immunotherapeutics · doi:10.1080/21645515.2017.1389362 · Cited by 28 · see citing works

Natural Vertical Transmission of Zika Virus in Larval Aedes aegypti Populations, Morelos, Mexico

Izquierdo-Suzán, M., Zárate, S., Torres-Flores, J. M., Morales, F. C., Acosta, C. G., Sevilla-Reyes, E. E., Lira, R., Alcaráz‐Estrada, S. L., & Yocupicio‐Monroy, M. (2019) · Emerging infectious diseases · doi:10.3201/eid2508.181533 · Cited by 27 · see citing works

Import of human miRNA-RISC complex into Plasmodium falciparum and regulation of the parasite gene expression

Dandewad, V., Vindu, A., Joseph, J., & Seshadri, V. (2019) · Journal of Biosciences · doi:10.1007/s12038-019-9870-x · Cited by 27 · see citing works

Neutralizing Monoclonal Antibodies as Promising Therapeutics against Middle East Respiratory Syndrome Coronavirus Infection

Han, H.-J., Liu, J.-W., Yu, H., & Yu, X. (2018) · Viruses · doi:10.3390/v10120680 · Cited by 25 · see citing works

Coronaviruses pandemics: Can neutralizing antibodies help?

Tong, P. B. V., Lin, L., & Tran, T. H. (2020) · Life Sciences · doi:10.1016/j.lfs.2020.117836 · Cited by 23 · see citing works

COVID-19: Current Developments and Further Opportunities in Drug Delivery and Therapeutics

Zafar, S., Arshad, M. S., Fatima, S., Ali, A. A. A., Zaman, A., Sayed, E., Chang, M., & Ahmad, Z. (2020) · Pharmaceutics · doi:10.3390/pharmaceutics12100945 · Cited by 23 · see citing works

Middle East Respiratory Syndrome Coronavirus in Dromedaries in Ethiopia Is Antigenically Different From the Middle East Isolate EMC

Shirato, K., Melaku, S. K., Kawachi, K., Nao, N., Iwata‐Yoshikawa, N., Kawase, M., Kamitani, W., Matsuyama, S., Tessema, T. S., & Sentsui, H. (2019) · Frontiers in Microbiology · doi:10.3389/fmicb.2019.01326 · Cited by 23 · see citing works

SARS-CoV-2 Spike Protein Extrapolation for COVID Diagnosis and Vaccine Development

Malik, Y. S., Kumar, P., Ansari, M. I., Hemida, M. G., Zowalaty, M. E. E., Abdel-Moneim, A. S., Ganesh, B., Tazerji, S. S., Natesan, S., Sircar, S., et al. (2021) · Frontiers in Molecular Biosciences · doi:10.3389/fmolb.2021.607886 · Cited by 23 · see citing works

Bacterial Outer Membrane Vesicles as Nano‐Scale Bioreactors: A Fatty Acid Conversion Case Study

Song, J., Baeg, Y., Jeong, H., Lee, J., Oh, D., Hollmann, F., & Park, J. (2021) · ChemCatChem · doi:10.1002/cctc.202100778 · Cited by 22 · see citing works

Evidence of Biocontrol Activity of Bioinoculants Against a Human Pathogen, Listeria monocytogenes

Sharma, R., Gal, L., Garmyn, D., Bisaria, V. S., Sharma, S., & Piveteau, P. (2020) · Frontiers in Microbiology · doi:10.3389/fmicb.2020.00350 · Cited by 21 · see citing works

Zika virus serological diagnosis: commercial tests and monoclonal antibodies as tools

Silva, I. B. B., da Silva, A. S., Cunha, M. S., Cabral, A. D., de Oliveira, K. C. A., Gaspari, E. D., & Prudêncio, C. R. (2020) · The Journal of venomous animals and toxins including tropical diseases · doi:10.1590/1678-9199-jvatitd-2020-0019 · Cited by 20 · see citing works

Protein nanoparticle vaccines induce potent neutralizing antibody responses against MERS-CoV

Chao, C. W., Sprouse, K. R., Miranda, M. C., Catanzaro, N., Hubbard, M. L., Addetia, A., Stewart, C., Brown, J. T., Dosey, A. M., Valdez, A., et al. (2024) · Cell Reports · doi:10.1016/j.celrep.2024.115036 · Cited by 17 · see citing works

Resistance analysis and treatment outcomes in hepatitis C virus genotype 3‐infected patients within the Italian network VIRONET‐C

Maio, V. C. D., Barbaliscia, S., Teti, E., Fiorentino, G., Milana, M., Paolucci, S., Pollicino, T., Morsica, G., Starace, M., Bruzzone, B. M., et al. (2021) · Liver International · doi:10.1111/liv.14797 · Cited by 16 · see citing works

Do we know how mosquito disease vectors will respond to climate change?

Andriamifidy, R. F., Tjaden, N. B., Beierkuhnlein, C., & Thomas, S. M. (2019) · Emerging Topics in Life Sciences · doi:10.1042/etls20180125 · Cited by 15 · see citing works

A high-throughput inhibition assay to study MERS-CoV antibody interactions using image cytometry

Rosen, O., Chan, L. L.-Y., Abiona, O. M., Gough, P., Wang, L., Shi, W., Zhang, Y., Wang, N., Kong, W., McLellan, J. S., et al. (2018) · Journal of Virological Methods · doi:10.1016/j.jviromet.2018.11.009 · Cited by 14 · see citing works

Zika virus: Molecular responses and tissue tropism in the mammalian host

Shaily, S., & Upadhya, A. (2019) · Reviews in Medical Virology · doi:10.1002/rmv.2050 · Cited by 14 · see citing works

Validation of a Saliva-Based Test for the Molecular Diagnosis of SARS-CoV-2 Infection

Bulfoni, M., Sozio, E., Marcon, B., Martino, M. D., Cesselli, D., Carlo, C. D., Martinella, R., Migotti, A., Vania, E., Zanus-Fortes, A., et al. (2022) · Disease Markers · doi:10.1155/2022/6478434 · Cited by 13 · see citing works

Characterization of a human monoclonal antibody generated from a B-cell specific for a prefusion-stabilized spike protein of Middle East respiratory syndrome coronavirus

Choi, J.-H., Woo, H., Lee, T.-Y., Lee, S. Y., Shim, S., Park, W.-J., Yang, J., Kim, J. A., Yun, M., Kim, D.-W., et al. (2020) · PLoS ONE · doi:10.1371/journal.pone.0232757 · Cited by 13 · see citing works

Pathomechanisms, therapeutic targets and potent inhibitors of some beta-coronaviruses from bench-to-bedside

Ayipo, Y. O., Yahaya, S. N., Alananzeh, W. A. A., Babamale, H. F., & Mordi, M. N. (2021) · Infection Genetics and Evolution · doi:10.1016/j.meegid.2021.104944 · Cited by 12 · see citing works

Self-reported snoring is associated with nonalcoholic fatty liver disease

Wang, H., Gao, Q., He, S., Bao, Y., Sun, H., Meng, L., Liang, J., Sun, C., Chen, S., Cao, L., et al. (2020) · Scientific Reports · doi:10.1038/s41598-020-66208-1 · Cited by 11 · see citing works

Microbial study of household hygiene conditions and associated Listeria monocytogenes infection risks for Peruvian women

Canales, R. A., Wilson, A. M., Sinclair, R., Soto‐Beltrán, M., Pearce-Walker, J. I., Molina, M., Penny, M. E., & Reynolds, K. A. (2019) · Tropical Medicine & International Health · doi:10.1111/tmi.13246 · Cited by 11 · see citing works

Specific Monoclonal Antibodies Targeting Unique HA Epitopes Block H7N9 Influenza A Viral Replication

Shen, W., Wang, Q., Wang, Z., Liu, M., Du, Y., Yuan, L., Han, L., Śmietanka, K., Chen, H., Xu, S., et al. (2022) · Journal of Virology · doi:10.1128/jvi.01238-22 · Cited by 10 · see citing works

An update on emerging therapeutics to combat COVID‐19

Shah, N. N., Nabi, S. U., Rather, M. A., Kalwar, Q., Ali, S. I., Sheikh, W. M., Ganai, A., & Bashir, S. M. (2021) · Basic & Clinical Pharmacology & Toxicology · doi:10.1111/bcpt.13600 · Cited by 10 · see citing works

RBD and Spike DNA-Based Immunization in Rabbits Elicited IgG Avidity Maturation and High Neutralizing Antibody Responses against SARS-CoV-2

da Costa, H. H. M., Orts, D. J. B., Moura, A. D., Duarte‐Neto, A. N., Cirqueira, C. D. S., Réssio, R. A., Kanamura, C. T., Miguita, K., Ferreira, J. E., Santos, R. T. D. M., et al. (2023) · Viruses · doi:10.3390/v15020555 · Cited by 11 · see citing works

Assessment of Physicochemical, Anticancer, Antimicrobial, and Biofilm Activities of N-Doped Graphene

Alangari, A., Aldakheel, F. M., Mateen, A., Alqhatani, M. S., Alaofi, A. L., Shahid, M., Ali, R., Syed, R., Adil, S. F., Khan, M., et al. (2022) · Crystals · doi:10.3390/cryst12081035 · Cited by 8 · see citing works

Cryoelectron microscopy structures of a human neutralizing antibody bound to MERS-CoV spike glycoprotein

Zhang, S., Jia, W., Zeng, J., Li, M., Wang, Z., Zhou, H., Zhang, L., & Wang, X. (2022) · Frontiers in Microbiology · doi:10.3389/fmicb.2022.988298 · Cited by 8 · see citing works

Development of an antibody-dependent cellular cytotoxicity reporter assay for measuring anti-Middle East Respiratory Syndrome antibody bioactivity

Cao, J., Wang, L., Yu, C., Wang, K., Wang, W., Yan, J., Li, Y., Yang, Y., Wang, X., & Wang, J. (2020) · Scientific Reports · doi:10.1038/s41598-020-73960-x · Cited by 8 · see citing works

ZIKAVID—Zika virus infection database: a new platform to analyze the molecular impact of Zika virus infection

da Rosa, R. L., Santi, L., Berger, M., Cagnini, E. F. T., Quincozes‐Santos, A., Souza, D. O., Guimarães, J. A., & Beys‐da‐Silva, W. O. (2019) · Journal of NeuroVirology · doi:10.1007/s13365-019-00799-y · Cited by 8 · see citing works

A potential new recombinant echovirus 18 strain detected in a 4-year-old child with encephalitis in China in 2019

Kang, Y., Hua, Y., Sun, M., Qian, J., & Zhu, P. (2021) · Archives of Virology · doi:10.1007/s00705-020-04907-w · Cited by 6 · see citing works

The structure of a novel antibody against the spike protein inhibits Middle East respiratory syndrome coronavirus infections

Jang, T., Park, W.-J., Lee, H., Woo, H., Lee, S., Kim, K.-C., Kim, S. S., Hong, E., Song, J., & Lee, J.-Y. (2022) · Scientific Reports · doi:10.1038/s41598-022-05318-4 · Cited by 6 · see citing works

Soil Collected from a Single Great Smoky Mountains Trail Contains a Diversity of Listeria monocytogenes and Listeria spp.

Claxton, M. L., Hudson, L. K., Bryan, D. W., & Denes, T. G. (2022) · Microbiology Spectrum · doi:10.1128/spectrum.01431-22 · Cited by 6 · see citing works

Structural characterization of human monoclonal antibodies targeting uncommon antigenic sites on spike glycoprotein of SARS-CoV

Suryadevara, N., Kose, N., Bangaru, S., Binshtein, E., Munt, J. E., Martinez, D. R., Schäfer, A., Myers, L., Scobey, T., Carnahan, R. H., et al. (2024) · Journal of Clinical Investigation · doi:10.1172/jci178880 · Cited by 5 · see citing works

MERS-CoV spike vaccine-induced N-terminal domain-specific antibodies are more protective than receptor binding domain-specific antibodies

Abiona, O. M., Wang, N., Leist, S. R., Schäfer, A., Cockrell, A. S., Wang, L., Bangaru, S., Stevens, L. J., Graham, R. L., Kocher, J., et al. (2024) · iScience · doi:10.1016/j.isci.2024.111632 · Cited by 5 · see citing works

Correlation between interleukin-28 gene polymorphism with interleukin-28 cytokine levels and viral genotypes among HCV patients in Yazd, Iran

Moghimi, M., Tavakoli, F., Doosti, M., Ahmadi-Vasmehjani, A., & Akhondi‐Meybodi, M. (2019) · BMC Research Notes · doi:10.1186/s13104-019-4651-z · Cited by 5 · see citing works

Broad neutralizing activity of a human monoclonal antibody against H7N9 strains from 2013 to 2017

Chen, C., Liu, Z., Liu, L., Xiao, Y., Wang, J., & Jin, Q. (2018) · Emerging Microbes & Infections · doi:10.1038/s41426-018-0182-2 · Cited by 4 · see citing works

Neutralizing monoclonal antibodies against highly pathogenic coronaviruses

Xiang, R., Wang, Y., Wang, L., Deng, X., Huo, S., Jiang, S., & Yu, F. (2021) · Current Opinion in Virology · doi:10.1016/j.coviro.2021.12.015 · Cited by 4 · see citing works

Lessons Learned from SARS-CoV and MERS-CoV: Preparation for SARS-CoV-2 induced COVID-19

Hong, S., Park, H., & Nam, J. (2020) · Journal of Bacteriology and Virology · doi:10.4167/jbv.2020.50.2.076 · Cited by 3 · see citing works

Serum ferritin, serum LDH and d-dimer in correlation with the outcome in Covid-19.

Kishan, J. H., Byalya, K., & Kumar, D. V. S. (2021) · International Journal of Medical Research and Review · doi:10.17511/ijmrr.2021.i01.07 · Cited by 3 · see citing works

The impact of high-resolution structural data on stemming the COVID-19 pandemic

Cox, R., & Plemper, R. K. (2021) · Current Opinion in Virology · doi:10.1016/j.coviro.2021.05.005 · Cited by 2 · see citing works

A Novel Antibody Against the Non–Receptor-Binding Domain Region of Middle East Respiratory Syndrome Coronavirus Spike Protein

Lee, S.-Y., Woo, H., Jeon, H., Kim, N.-Y., Kim, D. S., Park, C., Kim, H., Kim, K.-C., Lee, J.-Y., Park, K., et al. (2025) · The Journal of Infectious Diseases · doi:10.1093/infdis/jiaf202 · Cited by 1 · see citing works

Polyamines mediate enterovirus attachment directly and indirectly through cellular heparan sulfate synthesisPreprint

Hulsebosch, B. M., Omoba, O. S., LoMascolo, N. J., & Mounce, B. C. (2021) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2021.10.31.466121 · Cited by 1 · see citing works

Development of COVID-19 vaccines: A race against time!

Bhatia, M., & Rohilla, R. (2020) · Journal of Patient Safety & Infection Control · doi:10.4103/jpsic.jpsic_6_20

Vitamin D and Quercetin manifest properties of candidate medicinal agents for mitigation of the severity of pandemic COVID-19 defined by genomics-guided tracing of SARS-CoV-2 targets in human cells.Preprint

Glinsky, G. V. (2020) · ChemRxiv · doi:10.26434/chemrxiv.12052512.v6

Does COVID-19 Take a Breath? The Chinese Current SituationPreprint

Qadeer, A., Sohail, M., Younas, A., Iqbal, H., Ullah, A., Ullah, H., Razzaq, A., Menaa, B., Haq, I. U., Ahmed, Z., et al. (2021) · Preprints.org · doi:10.20944/preprints202104.0354.v1

Urological sequels in the scope of the Congenital Zika Syndrome

Monteiro, L. M. C. (2021) · Elsevier eBooks · doi:10.1016/b978-0-12-820268-5.00025-0

Vaccines’ Candidates Against SARS-CoV-2

ISI-SENAI-CIMATEC Group (2020) · Journal of Bioengineering, Technologies and Health · doi:10.34178/jbth.v3i2.126

A Novel Antibody Against the Non–Receptor-Binding Domain Region of Middle East Respiratory Syndrome Coronavirus Spike Protein

Lee, S.-Y., Woo, H., Jeon, H., Kim, N.-Y., Kim, D. S., Park, C., Kim, H., Kim, K.-C., Lee, J.-Y., Park, K., et al. (2025) · The Journal of Infectious Diseases · doi:10.1093/infdis/jiaf202 · Cited by 1 · see citing works

The structure of a novel antibody against the spike protein inhibits Middle East respiratory syndrome coronavirus infections

Jang, T., Park, W.-J., Lee, H., Woo, H., Lee, S., Kim, K.-C., Kim, S. S., Hong, E., Song, J., & Lee, J.-Y. (2022) · Scientific Reports · doi:10.1038/s41598-022-05318-4 · Cited by 6 · see citing works

Neutralizing Monoclonal Antibodies as Promising Therapeutics against Middle East Respiratory Syndrome Coronavirus Infection

Han, H.-J., Liu, J.-W., Yu, H., & Yu, X. (2018) · Viruses · doi:10.3390/v10120680 · Cited by 25 · see citing works

A Conformation-Dependent Neutralizing Monoclonal Antibody Specifically Targeting Receptor-Binding Domain in Middle East Respiratory Syndrome Coronavirus Spike Protein

Du, L., Zhao, G., Yang, Y., Qiu, H., Wang, L., Kou, Z., Tao, X., Yu, H., Sun, S., Tseng, C.-T. K., et al. (2014) · Journal of Virology · doi:10.1128/jvi.00433-14 · Cited by 138 · see citing works

The Receptor Binding Domain of the New Middle East Respiratory Syndrome Coronavirus Maps to a 231-Residue Region in the Spike Protein That Efficiently Elicits Neutralizing Antibodies

Mou, H., Raj, V. S., van Kuppeveld, F. J. M., Rottier, P. J. M., Haagmans, B. L., & Bosch, B. (2013) · Journal of Virology · doi:10.1128/jvi.01277-13 · Cited by 239 · see citing works